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FaradaymuthimarketThe Faraday traditional healers' trading market is the hub of the medicinal plant trade in Johannesburg, South
Africa. Modes of harvesting, transporting, storage and distribution of medicinal plants render them susceptible
to microbial attack, and thereby make customers, especially patients with compromised immune systems, vul-
nerable to infections that could increase morbidity andmortality. This study evaluated themicrobial contamina-
tion on ﬁve frequently used traditional medicinal plant species sold by traders in the Faraday market. Bacterial
contamination was determined using serial macro dilutions, spread plate and streak plate techniques. Fifteen
bacterial contaminants were identiﬁed, the most recurrent being Pantoea sp. and ﬁve strains of Bacillus spp.
(non-pathogenic). There was little variation between contamination levels of the ﬁve different traders, and the
mean CFU/g per species ranged from 3.03 × 104 (Hypoxis sp.) to 4.22 × 105 (Hydnora abyssinica). While there
was no overall signiﬁcant levels of contamination, the CFU counts for two plant species purchased from one spe-
ciﬁc trader (viz. H. abyssinica and Acacia xanthophloea) exceeded maximum acceptable contamination limits set
by theWorld Health Organisation (i.e.≤105 to≤107 CFU/g). The levels of contamination varied greatly between
the commercially available over the counter product and the plant samples investigated. Themicrobial types are
predominantly opportunistic pathogens. The implementation of good processing practices therefore clearly in-
ﬂuences the quality and safety of medicinal products, especially regarding microbial contamination. It is evident
that policies and regulations need to be developed and implemented in order to address possible contamination
by opportunistic pathogens.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
The use of traditional medicine, in particular medicines of plant ori-
gin, has increased worldwide since the 1990s due to its affordability,
availability, accessibility and the role inmeeting primary healthcare de-
mands in many developing African and Asian countries (WHO, 2008).
The number of practising traditional healers in South Africa is estimated
to be around 200,000, and up to 60% of the population reportedly con-
sult healers and use traditional medicines (umuthi) as their primary
source of healthcare (VanWyk et al., 2009). The use of umuthi is ﬁrmly
rooted in cultural and religious beliefs and is not exclusively a rural phe-
nomenon. These herbal medicines are also widely used for therapeutic
purposes in urban areas by more formally educated South Africans
in higher income brackets (Dold and Cocks, 2002; Mander et al.,
2008; Makunga et al., 2008; Ndhlala et al., 2011). Once described as
a “multi-million rand hidden economy” (Cunningham, 1991), the27 11 6424355.
uuren).
hts reserved.South African trade in traditional medicines was valued at R2.9 -
billion per annum in 2008 (Mander et al., 2008).
A host of environmental, agricultural, urban and industrial factors,
coupled with less than adequate harvesting, storage and processing
techniques, are causes of contamination in natural plant products that
compromises the quality and efﬁcacy of traditional medicines (Kneifel
et al., 2002; Street et al., 2008). Thus, in order to ensure the safety of con-
sumers, the fallacy that traditional medicinal plants are safe, ‘pure and
natural’ and pose no harm to users (Govender et al., 2006; Street et al.,
2008) must be challenged. To date, most of the plant research in the re-
lated ﬁeld has focussed on isolating and evaluating the active and/or
toxic compounds of herbal medicines in efforts to establish and validate
their safety and efﬁcacy. However, less research has been conducted
into assessing the occurrence of toxic substances and other contami-
nants that leave potentially detrimental residues and micro-organisms
on the plants (Street et al., 2008). Contaminating micro-organisms
and their toxins may lead to diseases, making them hazardous for con-
sumption (Govender et al., 2006). One of themajor contributing factors
to their growth is increased temperatures and moisture (Hell and
Mutegi, 2011). Previous studies on herbal medicines have found highly
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tant Staphylococcus aureus, various Bacillus species as well as multiple
fungal species such as Aspergillus ﬂavus, Penicillium viridicatum and
Fusarium oxysporum (Aziz et al., 1998; Govender et al., 2006; Stickel
et al., 2009; Kaume et al., 2012). Thus, caution is warranted regarding
the safety of contaminated plants in the outdoor informal umuthi
market trade where conditions are conducive to microbial exposure
and proliferation.
Much of the previous research on medicinal plant contamination by
microbes has assessed fungal species and the aﬂatoxins that they
produce (e.g. Katerere et al., 2008; Hell and Mutegi, 2011). This study,
however, focuses on bacterial contamination by enumerating the
types and levels of bacteria found on selected plants purchased from
the Faraday umuthimarket in Johannesburg, which has, to the best of
our knowledge, not been studied before. Faraday is a lively trading
hub and an important source of medicinal plants for the region. The
more than 200 vendors sell species harvested from across southern
Africa, but mainly from the provinces of Kwazulu-Natal, Eastern Cape,
Gauteng and Mpumalanga (Williams, 2007; Williams et al., 2011). The
majority of vendors sell plants from stalls that are mostly outdoors
and/or semi-exposed but protected from the rain by canopy roofs. The
remainder of the traders sell fromwithin naturally ventilated buildings.
Five commonly traded and identiﬁable plants were selected for
the study to assess levels of microbial contamination, namely:
Helichrysum sp. (iMphepho, leaves/stems), Drimia sanguinea
(isiKlenama/Skanama, bulb), Hypoxis sp. (iLabatheka, tuber),
Hydnora abyssinica (uMavumbuka, rhizome and root holoparasite)
and Acacia xanthophloea (umKhanyakude, bark) (Williams, 2007).
The underground plant parts of D. sanguinea, Hypoxis sp. and H.C
A
Fig. 1. A) Helichrysum sp. (iMphepho), B) Drimia sanguinea (isiKlenama/Skanama), C) Hypo
(umKhanyakude) as sold at the Faraday market and after processing.abyssinica are three of South Africa's most regularly used traditional
medicines, and are administered both orally and externally for a
wide variety of uses that may include ritual cleansing and washing
(e.g. Watt and Breyer-Brandwijk, 1962; Hutchings et al., 1996; Van
Wyk et al., 2009; Williams et al., 2011). In addition, the bulbs of
Drimia spp. contain a stinging sap that causes skin irritations
(Hutchings et al., 1996; Von Ahlefeldt et al., 2003).
The aromatic leaves and stems of Helichrysum sp. are generally not
administered orally, but are used in a ‘magical sense’ as an incense to
invoke the goodwill of the ancestors in rituals to cleanse a consecrated
place (Hutchings et al., 1996; Arnold et al., 2002; Street et al., 2012).
Thus, microbial contaminants present on plants are not necessarily of
major consumptive concern to users per se, but cross-contamination
with other plants is. The ﬂuorescent yellow bark of A. xanthophloea is
also used in a magical sense as a good luck charm, but powdered
bark decoctions and infusions are reported to be taken orally for
malaria and applied externally to treat eye conditions (Watt and
Breyer-Brandwijk, 1962; Hutchings et al., 1996; Arnold et al., 2002;
Hankey and Stern, 2002).
2. Materials and methods
2.1. Collection of samples
Three samples for each of the ﬁve plant species (Helichrysum
sp., Drimia sanguinea, Hypoxis sp., Hydnora abyssinica and Acacia
xanthophloea) (Fig. 1) were purchased from ﬁve different vendors
at the Faraday market (n = 75 samples). The ﬁve vendors (F1 to
F5) were randomly selected on the basis of plant availability andD
E
B
xis sp. (iLabatheka), D) Hydnora abyssinica (uMavumbuka) and E) Acacia xanthophloea
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ent areas that had varying levels of exposure to the outdoors.
Vendor F1 was situated outdoors on the eastern side of the market,
whereas vendors F2–F5 were distributed from east to west and
were under a canopy roof. The plant samples were collected in
the plastic packaging provided by the vendors. After collection,
the samples were placed in sterile autoclaved bags using sterile
gloves. All the samples were stored in the dark at room tempera-
ture until processing, which commenced within 48 h of purchasing
the samples.
For comparative purposes, three commercial samples of Panado®
with three different batch numbers were purchased at randomly select-
ed pharmacies and contained in their primary packaging until aseptic
processing commenced. Selection of the commercial sample with regu-
latedmanufacturing procedureswas based on consumer popularity and
was included in the study as a control, whereby comparison of commer-
cial pharmaceuticals could be compared to the samples from the infor-
mal trade.
2.2. Determining the presence of bacterial contamination
Each selected plant sample was weighed and placed in a sterile bea-
ker containing a measured volume of sterile water. The ratio of plant
weight to water volume was kept constant for all samples. The plant
samples were then agitated using a shaking incubator at 37 °C at
104 rpm for 1 h. After agitation, four 1:10 serial dilutions were per-
formed on the water collected from the samples. Each dilution was
homogenised using a vortex mixer and 1 ml sample plated onto to a
5% sheep blood agar plate using the spread plate method. The agar
plates were incubated at 37 °C for 24 h tomonitor detection of bacterial
contamination. After incubation, colony counts were performed on all
dilutions and colony forming units (CFU) per gram determined for
each sample. The study was undertaken in triplicate and expressed as
a mean of three replicate samples (Singh et al., 2008). The levels of bac-
terial contaminationwere compared to the limits set formedicinal plant
materials by the International Pharmacopoeia of the World Health Or-
ganisation (WHO, 2007). Acceptable colony counts range from ≤105
to≤107 CFU/g depending on the method of plant processing and prod-
uct administration to the user (WHO, 2007).
The commercial Panado® samples (one tablet in triplicate) were
weighed and placed in a sterile test tube containing ameasured volume
of sterile water in the same ratio as represented for the plant samples.
The samples were then further processed as for medicinal plant
samples.
2.3. Identiﬁcation of microbial species isolated
The different isolated colonies were streaked onto slanted transport
media and incubated at 37 °C for 24 h, after which they were immedi-
ately transported to the National Institute of Communicable Diseases
for identiﬁcation. Isolates were then streaked out onto 5% ColumbiaTable 1
Average number of colony forming units per gram (CFU/g) of sampled plant material (n = 3)
Plant sample No. of colonies in original inoculum (CFU/g plant materia
Trader F1 Trader F2 Trader F
Helichrysum sp. 3.89 × 104 8.66 × 104 8.66 × 1
Drimia sanguinea 4.67 × 104 3.11 × 104 3.11 × 1
Hypoxis sp. 1.61 × 105 a 2.00 × 104 2.00 × 1
Hydnora abyssinica 2.89 × 109 a,b 5.55 × 104 5.55 × 1
Acacia xanthophloea 1.00 × 108 a,b 1.11 × 104 1.11 × 1
Average CFU per trader 2.81 × 106 b 4.09 × 104 4.09 × 1
a CFU counts above those recommended for plant materials that have been pre-treated (e.g.
(allowable limit 107 CFU/g) (WHO, 2007).
b CFU counts above those recommended for other plant materials for internal use (allowablblood agar and MacConkey agar, and incubated at 37 °C overnight to
conﬁrm purity of isolates. A Gram stain was performed on each culture
and depending on the outcome, isolates were biochemically identiﬁed
using the VITEK Compact 2 automated system (BioMerieux, Marcy
I'Etoile, France) whereby 3 ml of sterile 0.5% saline was dispensed into
clear plastic tubes. Well isolated colonies were selected using a sterile
swab and transferred to the saline and then emulsiﬁed to obtain a ho-
mogeneous suspension with an opacity for Gram-negative isolates
equivalent to 0.50–0.63 McFarland standard and for Gram-positive iso-
lates, equivalent to 1.8–2.2 McFarland standard. For all Gram-negative
isolates a VITEK GN card was used and for all Gram-positive isolates,
VITEK BCL cards were used. These were placed in tubes with the bacte-
rial suspension and identiﬁcation was provided after 5–8 h.3. Results and discussion
The mean CFU for all samples purchased from ﬁve different traders
in the different areas of Faraday ranged from 3.03 × 104 CFU/g (Hypoxis
sp.) to 4.22 × 105 CFU/g (H. abyssinica) (Table 1). Samples from trader
F1 had the highest contamination levels (2.81 × 106 CFU/g), while sam-
ples from trader F5 were the least contaminated (4.16 × 103 CFU/g).
Sincemicrobial contamination counts for species purchased from trader
F1 were generally higher than samples purchased anywhere else in the
market, especially for H. abyssinica and A. xanthophloea, it is probable
that plant contamination levels may be (a) trader-speciﬁc (rather than
species-speciﬁc), (b) related to the location of the vendors' stalls in
the market, (c) inﬂuenced by the degree of exposure (including air-
borne) and handling, and (d) the amount of cross-contamination.
Since area F1 was more exposed to environmental factors, with higher
numbers of human trafﬁc in the vicinity, this may have contributed to-
wards the higher CFUs encountered.
In terms of the World Health Organisation's microbial contamina-
tion limits for medicinal plant materials intended for internal use, the
colony counts should not exceed 105 CFU/g (WHO, 2007). Furthermore,
for plant products intended for topical use or those that are pre-treated
with boilingwater, the colony count should not exceed 107 CFU/g. Thus,
bacterial contamination on samples ofH. abyssinica and A. xanthophloea
purchased from trader F1 exceeds the maximum acceptable levels for
both internal and external use (Table 1). The results for Drimia
sanguinea and Hypoxis sp. indicate that CFU counts are within limits ac-
ceptable for internal and topical use. Since Helichrysum sp. is usually
burned and not ingested, the CFU counts are also acceptable, but the
species could be a vector for the broader transmission of bacteria
given its popularity in the market.
The control samples (Pando® tablets), showed bacterial contamina-
tion but only on one of the three control samples of Panado® where
1.00 × 102 CFU/g was observed. The level of contaminationwas notably
much lower than that found in the plant samples. The implementation
of good manufacturing and processing practices therefore clearly inﬂu-
ences the quality and safety of medicinal products, especially with
regards to microbial contamination..
l) per sampled area
3 Trader F4 Trader F5 Average CFU per species
04 7.91 × 105 b 1.60 × 104 5.82 × 104
04 6.44 × 104 8.89 × 103 5.24 × 104
04 7.78 × 103 1.78 × 103 3.03 × 104
04 1.02 × 106 b 6.11 × 104 4.22 × 105 b
04 9.89 × 104 2.44 × 103 3.11 × 105 b
04 6.61 × 104 4.16 × 103
as for infusions or decoctions using boiling water) or that are used as topical dosage forms
e limit 105 CFU/g) (WHO, 2007).
Table 2
Identiﬁcation of contaminants from samples of ﬁve plant species purchased at the Faraday umuthimarket.
Micro-organism
identiﬁed
Helichrysum
sp.
Drimia
sanguinea
Hypoxis
sp.
Hydnora
abyssinica
Acacia
xanthophloea
Incidence
of micro-
organism
Associated pathogenesis
Acinetobacter
baumannii
F4 1 Opportunistic pathogen that may cause bacteremia, pneumonia, meningitis,
urinary tract infection and wound infections (Maragakis and Perl, 2008)
Acinetobacter lwofﬁi F3 1 Cause of infections in patients with impaired immune systems; cause of
nosocomial infections e.g. septicaemia, pneumonia, meningitis, urinary tract
infections, skin and wound infections (Regalado et al., 2009)
Bacillus
amyloliquefaciens
F4 1 None
Bacillus lentus F5 1 None
Bacillus megaterium F3 F4 2 None
Bacillus subtilis F5 1 None
Bacillus vallismortis F4 1 None
Enterobacter cloacae F5 F4 2 Opportunistic pathogen that can be acquired through the skin, gastrointestinal
tract and urinary tract; cause of nosocomial bloodstream infections (Mezzatesta
et al., 2012)
Klebsiella oxytoca F2 1 Opportunistic pathogen most often involving immunocompromised patients
(Lowe et al., 2012)
Leclercia adecarboxylata F1 1 Opportunistic pathogen (Stock et al., 2004)
Pantoea species F1, F3 F1 F1, F3,
F4
F3 F3 8 Some species are opportunistic pathogens causing wound, blood, and urinary
tract infections
Pseudomonas
oryzihabitans
F3, F5 2 Infections in immuno-compromised patients (Iglesias and Martínez, 2004;
Decker et al., 1991)
Sphingomonas
paucimobilis
F3 1 Opportunistic pathogen (Ryan and Adley, 2010)
Streptococcus mitis F2 1 Infections associated with immuno-compromised patients (Bannister et al.,
2000)
Staphylococcus hominis 1a Harmless commensal on humans and animals but may cause infection in
patients whose immune systems are compromised
Type no's of micro-
organisms identiﬁed
per plant species
3 7 3 4 3 15
Incidence of micro-
organisms identiﬁed
per species
5 7 5 4 3 24
a Panado® control.
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identity of colonies found is imperative, since low levels of pathogenic
strains may have more adverse effects than higher levels of non-
pathogenic organisms. Fifteen types of micro-organisms were identi-
ﬁed, the most recurrent of which were Pantoea species (present on
eight samples between all ﬁve plant species purchased from three
traders) and Bacillus spp. (present on six samples of three species;
four types identiﬁed on D. sanguinea) (Table 2). Many of these organ-
isms are residents of the soil, water and natural environment and
hence it is conceivable that they were already residing on the plant ma-
terial and not introduced from a secondary source. With the exception
of the Bacillus species, which are non-pathogenic,most of the organisms
are capable of causing infections in immuno-compromised patients (es-
pecially Pseudomonas oryzihabitans in patients with HIV). The preva-
lence of Bacillus spp. is possibly due to its spore forming nature. Four
of the seven micro-organisms identiﬁed on D. sanguinea tended to be
non-pathogenic, whereas all four types identiﬁed on H. abyssinica
were usually opportunistic, pathogenic and capable of causing infec-
tions (Table 2). No Staphylococcus strains were recovered in this study.
It is important for researchers to be cognisant of environmental
contaminants and the effects thereof when reporting on the activity
and efﬁcacy of crude plant extracts (Street et al., 2008). Bacterial and
fungal contamination can occur at different entry points along the me-
dicinal plant trade chain, fromharvesting to the loci of sale in theumuthi
market and can critically inﬂuence the quality of the product that the
consumer receives (Zhang et al., 2012). The risk of contamination
often increases when harvesting is done in areas with high tempera-
tures and humidity orwhen plants are collected during the rainy season
(WHO, 2003). KwaZulu-Natal, the main source of supply for plants soldin the Faradaymarket (Williams, 2004), has a sub-tropical climate with
high ambient humidity throughout the year. This increases the risks of
microbial growth.
Themodebywhichplants are conveyed tomarkets further increases
the risk of microbial cross-contamination (Katerere et al., 2008). Most
species are packaged in reused plastic or hessian bags that previously
contained maize products and which, if contaminated, can act as
vectors for micro-organisms such as Aspergillus species (a producer of
various carcinogenic aﬂatoxins) (Katerere et al., 2008). Similarly, pack-
aging infected with bacterial contaminants would enable opportunistic
transmission and cross-contamination. Once plants reach the markets
they are stored uncovered, exposed to air contaminants and hence are
rendered susceptible to further adverse environmental conditions and
microbial attack. Plants sold by trader F1, for example, and to a reduced
degree trader F4, had CFU/g counts higher than plants sold by the other
traders. F1 was in an area of themarket that wasmore exposed and had
a greater volume of human trafﬁc, whereas the other traders were in
more enclosed sections of the market. While the manner in which the
bacteria were introduced on the plant samples remains unknown, the
most frequently occurring contaminants appear to be harmless and
may have originated at the sites where the plants were harvested.
Some of the potentially harmful pathogenic bacteria identiﬁed on the
samples may, however, be indicative of unsanitary and unhygienic con-
ditions and methods of product handling and processing.
The potential for the growth of micro-organisms can by limited by
drying the herbal medicines after harvesting (Jordan et al., 2010), and
underground and wetter plant parts may be more susceptible than
aerial parts to contamination (Katerere et al., 2008). However, the rela-
tively dry bark of A. xanthophloea and the dried leaves and stems of
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ly when compared to thewettermaterial of the remaining three species
(Table 2). These results are indicative of the complexity of the contam-
ination processeswithin open informalmarkets such as Faraday and the
challenges for regulating, controlling and preventing potential bacterial
infections. These challenges are further compounded by a lack of con-
cern amongst some consumers who believe that the more unhygienic
some speciﬁc products look, the more efﬁcacious they are (Katerere
et al., 2008).
Although the cultural signiﬁcance, beliefs, plants and other rawmate-
rials usedwith regards to traditionalmedicinesmay differ from onemar-
ket and one country to the next, concerns related to the contamination of
these plants are universal. A study on themicrobial quality of herbalmed-
icines from shops in the Nelson Mandela Metropole (Port Elizabeth),
South Africa (Govender et al., 2006) found signiﬁcant contamination by
bacteria and fungi. Of particular concern was the evidence of resistant
strains of Staphylococcus aureus. It was interesting and surprising to
note that no Escherichia coli or S. aureus contaminants were evident on
the samples from this study. The study by Govender et al. (2006), togeth-
erwith concerns raised by Fennell et al. (2004) and Street et al. (2008) re-
garding the informal medicinal plant trade of South Africa, conﬁrm the
need to continuously monitor contamination levels. Similarly, contami-
nation of herbalmedicines by bacteria and fungi have been found in stud-
ies conducted in China, Indonesia, Brazil, Malaysia and India (Zhang et al.,
2012). This evidence supports the notion that the problems associated
with the contamination of herbal medicinal plants are a global phenom-
enon for which appropriate regulation couldmitigate against factors that
have negative consequences for human health and safety.4. Conclusion
Even though the levels of contamination present on the samples in
question are generally below the levels recommended by the World
Health Organisation and together with the fact that the organisms are
likely to be merely commensals, immuno-compromised patients are
nevertheless at risk of developing disease due to such contamination.
It is therefore pertinent that the safety of these products is of primary
concern to healthcare providers in South Africa. Faraday, or any other
similar trading market like it, is a market for traditional medicine and
therefore attracts sick patients.Microbial contamination could addition-
ally be attributed to these customers and is not necessarily caused by
any unhygienic practises by the vendors and harvesters from the mar-
ket. To control any contamination from this source, one would have to
regulate the contact with customers and the plants. This may add
even further complexity to ﬁnding a solution to contamination.
This study therefore brings the problems associated with microbial
contamination to the forefront and aims to inﬂuence policy makers,
healthcare workers, traditional herbalists and healers, traders and con-
sumers, to consider prevention strategies that ensure the safe and effec-
tive use of these medicinal plants.Acknowledgements
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